menu
    • menu

    Company profile for Nucleai

    NEW Drugs in Dev: 1
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Nucleai’s platform unlocks spatial insights. In Nucleai Atom, your pathology slides are transformed into raw data of cell and area locations. The raw data is fed into the Nucleai engine, computing hundreds of spatial features intersected with outcome to predict drug response.We are committed to bringing the power of spatial biology to reality by providing pharmaceutical companies and clinicians with AI-powered image analysis...
    Nucleai’s platform unlocks spatial insights. In Nucleai Atom, your pathology slides are transformed into raw data of cell and area locations. The raw data is fed into the Nucleai engine, computing hundreds of spatial features intersected with outcome to predict drug response.We are committed to bringing the power of spatial biology to reality by providing pharmaceutical companies and clinicians with AI-powered image analysis applications. Our platform enhances drug development, supports treatment decisions and improves patient lives.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NucleaiUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1375 W Fulton Ave, Chicago, IL 60607, US Suite 650
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://nucleai.ai/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/nucleai-ai/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Arvo

    Arvo

    Not Confirmed

    envelop Contact Supplier

    Arvo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nucleai, Sirona Dx Partner For Integrated Spatial Proteomics
    Nucleai, Sirona Dx Partner For Integrated Spatial Proteomics

    15 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-15/nucleai-and-sirona-dx-partner-to-deliver-an-integrated-spatial-proteomics-solution-for-pharma-drug-d

    PHARMIWEB
    15 Apr 2026
    Share Share
    Nucleai Empowers Lung Cancer Treatment Response Study In Nature
    Nucleai Empowers Lung Cancer Treatment Response Study In Nature

    03 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260203091757/en/Nucleai-Enables-Spatial-Biology-Research-in-Nature-Communications-Study-on-Lung-Cancer-Treatment-Response

    BUSINESSWIRE
    03 Feb 2026
    Share Share
    Nucleai Partner to Multimodal Medicine for Colorectal Cancer
    Nucleai Partner to Multimodal Medicine for Colorectal Cancer

    12 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251112472697/en/Nucleai-and-University-of-Glasgow-Partner-to-Pioneer-Multimodal-Precision-Medicine-for-Colorectal-Cancer

    BUSINESSWIRE
    12 Nov 2025
    Share Share
    Bio-Techne, Nucleai Introduce Ai Workflow For Biomarker
    Bio-Techne, Nucleai Introduce Ai Workflow For Biomarker

    04 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ai-powered-spatial-biology-workflow-from-bio-techne-and-nucleai-enables-predictive-biomarker-discovery-in-melanoma-patients-302604119.html

    PR NEWSWIRE
    04 Nov 2025
    Share Share
    Nucleai Launches Deep Learning Model for Biomarker Discovery
    Nucleai Launches Deep Learning Model for Biomarker Discovery

    22 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250422702331/en/Nucleai-Launches-First-of-its-Kind-Deep-Learning-Model-to-Automate-Spatial-Proteomics-Accelerating-Biomarker-Discovery-for-ADCs-Bispecifics-and-Immunotherapy

    BUSINESSWIRE
    22 Apr 2025
    Share Share
    Nucleai Highlights AI Biomarkers for Lung & Skin Cancer at SITC
    Nucleai Highlights AI Biomarkers for Lung & Skin Cancer at SITC

    05 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241105887582/en

    BUSINESSWIRE
    05 Nov 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search